116
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Multiple Pathway–Mediated Gut-Modulatory Effects of Maerua subcordata (Gilg) DeWolf

ORCID Icon, , ORCID Icon, ORCID Icon & ORCID Icon
Pages 203-211 | Published online: 14 Jul 2020

References

  • Occhipinti K, Smith JW. Irritable bowel syndrome: a review and update. Clin Colon Rectal Surg. 2012;25(01):046–052. doi:10.1055/s-0032-1301759
  • Annaházi A, Rók R, Rosztóczy A, et al. Role of antispasmodics in the treatment of irritable bowel syndrome. World J Gastroenterol. 2014;20(20):6031. doi:10.3748/wjg.v20.i20.6031
  • Rokaya MB, Uprety Y, Poudel RC, et al. Traditional uses of medicinal plants in gastrointestinal disorders in Nepal. J Ethnopharmacol. 2014;158:221–229. doi:10.1016/j.jep.2014.10.014
  • Gilani AH, Atta-ur-Rahman. Trends in Ethnopharmacology. J Ethnopharmacol. 2005;100:43–49. doi:10.1016/j.jep.2005.06.001
  • Patwardhan B, Ashok Vaidy DB, Chorghade M. Ayurveda and natural products drug discovery. Curr Sci. 2004;86(6):789–799.
  • Chhabra S, Mahunnah R, Mshiu E. Plants used in traditional medicine in Eastern Tanzania. II. Angiosperms (Capparidaceae to Ebenaceae). J Ethnopharmacol. 1989;25(3):339–359. doi:10.1016/0378-8741(89)90038-X
  • Mabogo DEN, van Wyk AE The Ethnobotany of the Vhavenda. Master’s Thesis, University of Pretoria, Pretoria–South Africa; 1990.
  • Magaji MG, Yaro AH, Maiha BB, et al. Preliminary gastrointestinal studies on aqueous methanolic stem bark extract of Maerua angolensis (CAPPARACEAE). Nigerian J Pharmaceut Sci. 2008;7(1):108–113.
  • Geissler PW, Harris SA, Prince RJ, et al. Medicinal plants used by Luo mothers and children in Bondo district, Kenya. J Ethnopharmacol. 2002;83:39–54. doi:10.1016/S0378-8741(02)00191-5
  • Diallo D, Hveem B, Mahmoud M, et al. An ethnobotanical survey of herbal drugs of Gourma District, Mali. Pharmaceut Biol. 1999;37(1):80–91. doi:10.1076/phbi.37.1.80.6313
  • Abouri M, El Mousadik A, Msanda F, et al. An ethnobotanical survey of medicinal plants used in the Tata Province, Morocco. Int J Med Plant Res. 2012;1(7):099–123.
  • Akuodor GC, Ibrahim JA, Akpan JL, et al. Phytochemical and Anti-diarrhoeal Properties of Methanolic Leaf Extract of Maerua crassifolia Forssk. Europ J Med Plants. 2014;4(10):1223–1231. doi:10.9734/EJMP/2014/11246
  • Heuzé V, Tran G, Delagarde R, Renaudeau D. Atil (Maerua crassifolia). Feedipedia, a programme by INRA, CIRAD, AFZ and FAO, 2015. 2015;14:32.
  • Agize M, Demissew S, Asfaw Z. Ethnobotany of medicinal plants in Loma and Gena bosa districts (woredas) of dawro zone, southern Ethiopia. Topclass J Herbal Med. 2013;2(9):194–212.
  • Andarge E, Shonga A, Agize M, et al. Utilization and conservation of medicinal plants and their associated indigenous knowledge (IK) in Dawuro Zone: an ethnobotanical approach. Int J Med Plant Res. 2015;4:330–337.
  • Teklehaymanot T, Giday M. Ethnobotanical study of wild edible plants of Kara and Kwego semi-pastoralist people in Lower Omo River Valley, Debub Omo Zone, SNNPR, Ethiopia. J Ethnobiol Ethnomed. 2010;6:23. doi:10.1186/1746-4269-6-23
  • Hassan-Abdallah A, Merito A, Hassan S, et al. Medicinal plants and their uses by the people in the Region of Randa, Djibouti. J Ethnopharmacol. 2013;148:701–713. doi:10.1016/j.jep.2013.05.033
  • Morgan AMA, Lim CH, Kim YH. Lignans, cyclolignans and neolignans from the leaves of Boscia senegalensis (Pers.) Lam. ex Poir. Biochem Systematics Ecol. 2015;59:226–228. doi:10.1016/j.bse.2015.01.020
  • Hiben MG, Louisse J, de Haan LHJ, et al. Ethnomedicine and ethnobotany of Maerua subcordata (Gilg) DeWolf. J Ethnic Foods. 2019a;6:23. doi:10.1186/s42779-019-0032-4
  • Rehman N, Khan A, Fatima U, et al. Presence of laxative and antidiarrheal activities in Periploca aphylla: a Saudi medicinal plant. Int J Pharmacol. 2013;9:190–196. doi:10.3923/ijp.2013.190.196
  • NRC (National Research Council). Guide for the Care and Use of Laboratory Animals. Washington: National Academy Press; 1996:1–7.
  • NRC (National Research Council). Guide for the Care and Use of Laboratory Animals. National Academies Press; 2010.
  • Albus U. Guide for the Care and Use of Laboratory Animals. 8th ed. London, England: SAGE Publications Sage UK; 2012.
  • OECD/OCDE. OECD Guideline for the Testing of Chemicals. Acute Oral Toxicity; Up-And-Down Procedure (UDP). Paris, France: OECD; 2008.
  • Khan M, Khan A, Gilani AH. Pharmacological basis for the medicinal use of Morus alba in gut and airways disorders. Bangladesh J Pharmacol. 2012;7(4):289–298. doi:10.3329/bjp.v7i4.12873
  • Mandukhail S, Ahmed AF, Al-Yousef HM, et al. The mechanism underlying the spasmolytic and bronchodilatory activities of the flavonoid-rich red onion” Allium cepa L.” Peel extract. Int J Pharmacol. 2014;10(2):82–89. doi:10.3923/ijp.2014.82.89
  • Farre AJ, Colombo M, Fort M, et al. Differential effects of various Ca2+ antagonists. Gen Pharmacol. 1991;22(1):177–181. doi:10.1016/0306-3623(91)90331-Y
  • Godfraind T, Miller R, Wibo M. Calcium antagonism and calcium entry blockade. Pharmacol Rev. 1986;38:321–416.
  • Lorenz KL, Wells J. Potentiation of the effects of sodium nitroprusside and of isoproterenol by selective phosphodiesterase inhibitors. Mol Pharmacol. 1983;23(2):424–430.
  • Cook NS. The pharmacology of potassium channels and their therapeutic potential. Trends in Pharmacol Sci. 1989;9(1):21–28. doi:10.1016/0165-6147(88)90238-6
  • Etkin NL, Ross PJ. Food as Medicine and Medicine as Food. An adaptive framework for the interpretation of plant utilization Among the Hausa of Northern Nigeria. Soc Sci Med. 1982;16:1559–1573. doi:10.1016/0277-9536(82)90167-8
  • Waterman C, Smith RA, Pontiggia L, et al. Anthelmintic screening of Sub-Saharan African plants used in traditional medicine. J Ethnopharmacol. 2010;127(3):755–759. doi:10.1016/j.jep.2009.11.025
  • Reynolds I, Gould RJ, Snyder SH. Loperamide: blockade of calcium channels as a mechanism for antidiarrheal effects. J Pharmacol Exper Ther. 1984;231(3):628–632.
  • Iwao I, Terada Y. On the mechanism of diarrhoea due to castor oil. Jap J Pharmacol. 1962;12:137–145. doi:10.1254/jjp.12.137
  • Croci T, Landi M, Elmonds-Alt X, et al. Role of tachykinins in castor oil-induced diarrhea in rats. Br J Pharmacol. 1997;121:375–380. doi:10.1038/sj.bjp.0701130
  • Ali MZ, Janbaz KH, Mehmood MH, et al. Antidiarrheal and antispasmodic effects of Polygonum bistorta rhizomes are mediated predominantly through K+ channels activation. Bangladesh J Pharmacol. 2015;10:627–634. doi:10.3329/bjp.v10i3.23714
  • Gilani AH, Shaheen F, Christopoulos A, et al. Interaction of ebeinone, an alkaloid from Fritillaria imperialis, at two muscarinic acetylcholine receptor subtypes. Life Sci. 1997;60:535–544. doi:10.1016/S0024-3205(96)00691-1
  • McLean WFH, Blunden G, Jewers K. Quatenary ammonium compounds in the Capparaceae. Biochem Systematics Ecol. 1996;24(5):427–434. doi:10.1016/0305-1978(96)00044-0
  • Hiben MG, de Haan L, Spenkelink B, et al. Effects of Maerua subcordata (Gilg) DeWolf on electrophile-responsive element (EpRE)-mediated gene expression in vitro. PLoS One. 2019;14(4):e0215155. doi:10.1371/journal.pone.0215155
  • Hobbiger F, Mitchelson F, Rand MJ. The actions of some cholinomimetic drugs on the isolated taenia of the guinea-pig caecum. Br J Pharmacol. 1969;36:53–69. doi:10.1111/j.1476-5381.1969.tb08303.x
  • Fleckenstein A. Specific pharmacology of calcium in myocardium, cardiac pacemakers, and vascular smooth muscle. Ann Rev Pharmacol. 1977;17:149–166. doi:10.1146/annurev.pa.17.040177.001053
  • Rang H, Dale M, Ritter J, et al. Textbook of Pharmacology. UK: Churchill Livingstone; 1999:199–242.
  • Kaneda T, Takeuchi Y, Matsu H, et al. Inhibitory mechanism of papaverine on carbachol-induced contraction in bovine trachea. J Pharmacol Sci. 2005;98:275–282. doi:10.1254/jphs.FPJ05013X
  • Takayanagi I, Uchida M, Inatomi N, et al. Intracellular cyclic adenosine 3,5-monophosphate and relaxing effects of isoprenaline and papaverine on smooth muscle of intestine. Jap J Pharmacol. 1972;22:869–871. doi:10.1254/jjp.22.869
  • Frank H, Puschmann A, Schusdziarra V, et al. Functional evidence for a glibenclamide-sensitive K+ channel in rat ileal smooth muscle. Europ J Pharmacol. 1994;271:379–386. doi:10.1016/0014-2999(94)90797-8
  • Empfield JR, Russell K, Trainor DA. Potassium channel openers: therapeutic possibilities. Pharmaceut News. 1995;6:23–27.
  • Mannhold R. K+ ATP channel openers: structure-activity relationships and therapeutic potential. Med Res Rev. 2004;24:213–266. doi:10.1002/med.10060
  • Quast U. Potassium channel openers: pharmacological and clinical aspects. Fundam Clin Pharmacol. 1992;6(7):279–293. doi:10.1111/j.1472-8206.1992.tb00122.x
  • Lenz T, Wagner G. Potential Role of Potassium Channel Openers for the Treatment of Cardiovascular Disease. New York: Raven Press; 1995.
  • Findling R, Frishman W, Javed MT, et al. Calcium channel blockers and the gastrointestinal tract. Am J Ther. 1996;3:383–408. doi:10.1097/00045391-199605000-00009
  • Schwarz ER, Kapur V, Rodriguez J, et al. The effects of chronic phosphodiesterase-5 inhibitor use on different organ systems. Int J Impot Res. 2007;19:139–148. doi:10.1038/sj.ijir.3901491
  • Nawrath H. Action potential, membrane currents and force of contraction in cat ventricular heart muscle treated with papaverine. J Pharmacol Exper Therapeut. 1981;218(2):544–549.
  • Billman GE. The antiarrhythmic and antifibrillatory effects of calcium antagonists. J Cardiovas Pharmacol. 1991;18:S107–117. doi:10.1097/00005344-199118101-00019